Feasibility of metal stent for removal of common bile stones in patients with dual antiplatelet therapy

Feasibility and safety of metal stent for removal of common bile stones in patients with dual antiplatelet therapy. : A single center, open, investigator initiated trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002151

Enrollment

Registered

2016-11-25

Start date

2015-11-15

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : To remove common bile duct stones during ERCP (endoscopic retrograde cholangiopancreatogram), balloon dilatation or endoscopic sphincterotomy is needed. However, these techniques caus

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with common bile duct stones taking dual antiplatelet agents (Dual antiplatelet agents: aspirin + clopidogrel or aspirin + prasugrel) 2. Patients who agreed to the informed consent

Exclusion criteria

Exclusion criteria: 1. Patients who did not agree to the informed conset 2. Patients with severe psychiatric disorders 3. Patients with severe comorbidity (end-stage renal disease, advanced chronic obstructive pulmonary disease, severe heart failure) 4. Patient with history of anaphylaxis to contrast agents 5. Patients with previous endoscopic sphincterotomy 6. Pregnant patients

Design outcomes

Primary

Measure	Time frame
post-ERCP bleeding after common bile duct stone removal	—

Secondary

Measure	Time frame
Success rates of common bile duct stone removal ;Total procedure time of common bile duct stone removal ;post-ERCP complications other than bleeding	—

Countries

Korea, Republic of

Contacts

Public ContactEunae Cho

Chonnam National University Hospital

cea202@hanmail.net+82-62-220-6215

Outcome results